Skip to content

Study on the Group-based Trajectory and Influencing Factors of Activation Level among Elderly Colorectal Cancer Patients and Their Family Caregivers

Study on the Group-based Trajectory and Influencing Factors of Activation Level among Elderly Colorectal Cancer Patients and Their Family Caregivers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113331
Enrollment
Unknown
Registered
2025-11-27
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients: 1. Age >= 60 years old. 2. Patients who meet the relevant diagnostic criteria in China Colorectal Cancer Diagnosis and Treatment Guidelines (2023 Edition) and are pathologically confirmed as having primary colon cancer or rectal cancer. 3. Patients with clear consciousness, normal cognitive function, basic reading and writing skills, and no communication barriers with researchers. 4. Patients who voluntarily participate in this study and sign the informed consent form (ICF). If a subject is unable to read and sign the ICF due to incapacity or other reasons, their legal guardian shall act as a proxy in the informed consent process and sign the ICF. If a subject is unable to read the ICF (e.g., illiterate subjects), a witness shall witness the informed consent process and sign the ICF. Caregivers: 1. Age >= 18 years old. 2. Having a kinship relationship with the patient (e.g., spouse, children, parents, siblings) and providing non-professional or unpaid care for the patient; if there are multiple caregivers, the one with the longest caregiving duration shall be included in this study. 3. Voluntarily participate in this study and sign the informed consent form (ICF). If a subject is unable to read and sign the ICF due to incapacity or other reasons, their legal guardian shall act as a proxy in the informed consent process and sign the ICF. If a subject is unable to read the ICF (e.g., illiterate subjects), a witness shall witness the informed consent process and sign the ICF.

Exclusion criteria

Exclusion criteria: Patients: 1. In critical condition with an expected survival time of < 6 months. 2. Currently participating in other clinical studies. 3. Vulnerable groups other than the elderly or illiterate, including patients with mental illnesses, patients with cognitive impairments, critically ill patients, pregnant women, etc. Caregivers: 1. With cognitive impairment or communication impairment. 2. Currently participating in other clinical studies. 3. With severe physical illnesses and/or mental illnesses. 4. Vulnerable groups other than the elderly or illiterate, including patients with cognitive impairments, critically ill patients, pregnant women, etc.

Design outcomes

Primary

MeasureTime frame
Patient's health-related quality of life;Patient activation;Caregiver's health-related quality of life;Caregiver activation;

Countries

China

Contacts

Public ContactXuemei Xian

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

xianxuemei@zju.edu.cn+86 571 8600 2140

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026